Myung-Sook Choi

This inventor holds 15 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Korea Institute of Science and Technology, Korea Research Institute of Bioscience and Biotechnology, Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 1998-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Myung-Sook Choi. Retrieved from https://idiyas.com/inventor/myung-sook-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 3)

% Patents Active = 86.7

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 10.5

ph-index = 8

Forward Citations = 490(Granted Patents)

Location History:

Dong-gu Daegu, KR (2020)
Daegu, KR (1998 - 2021)

Company Filing History:

7 out of 2,248

Korea Institute of Science and Technology

patents

7 out of 334

Korea Research Institute of Bioscience and Biotechnology

patents

1 out of 365

Kyungpook National University Industry-Academic Cooperation Foundation

patents

Years Active: 1998-2021

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11083767 - Pharmaceutical composition comprising an extract of platycodon grandiflorum and method for preventing or treating of obesity using the same (2021-08-10),

2. 10765128 - Composition for prevention or treatment of metabolic syndrome or for antioxidation containing black bean leaf extracts and flavonol glysosides isolated therefrom as active ingredients (2020-09-08),

3. 9381222 - Compositions for preventing and treating obesity, hyperlipidemia, atherosclerosis, fatty liver, diabetes or metabolic syndrome containing extracts of glycine max leaves or fractions isolated from the same as an active ingredient (2016-07-05),

4. 6562866 - Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin (2003-05-13),

5. 6509372 - Method for preventing or treating elevated blood lipid level-related diseases by administering rutin and quercetin (2003-01-21),

6. 6465019 - Health-improving spice composition (2002-10-15),

7. 6455577 - Flavanone derivatives and composition for preventing or treating blood lipid level-related diseases comprising same (2002-09-24),

8. 6313171 - Method for preventing or treating elevated blood lipid level-related diseases by administering cinnamic acid derivatives (2001-11-06),

9. 6165984 - Naringin and naringenin as inhibitors of acyl (2000-12-26),

10. 6133311 - Method for preventing or treating elevated blood lipid level-related (2000-10-17),

11. 6133241 - Bioflavonoids as plasma high density lipoprotein level increasing agent (2000-10-17),

12. 6096364 - Method for lowering blood glucose level by the administration of (2000-08-01),

13. 5877208 - Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) (1999-03-02),

14. 5792461 - Citrus peel extract as 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase (1998-08-11),

15. 5763414 - Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) (1998-06-09),

Title: Myung-Sook Choi: Innovator in Pharmaceutical Composition and Metabolic Health

Introduction

Myung-Sook Choi is a prominent inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the prevention and treatment of obesity and metabolic syndrome. With a total of 15 patents to his name, Choi's work is recognized for its innovative approaches to health and wellness.

Latest Patents

Choi's latest patents include a pharmaceutical composition comprising an extract of Platycodon grandiflorum aimed at preventing or treating obesity. This composition demonstrates an ability to inhibit increases in body weight and fat mass caused by a high-fat diet. It also shows improvements in fasting blood glucose levels and energy expenditure in diet-induced obesity mouse models. Compared to conventional extraction methods, Choi's extract exhibits superior anti-obesity effects, making it a promising candidate for addressing obesity-related complications.

Another notable patent involves a composition for the prevention or treatment of metabolic syndrome, which includes black soybean leaf extracts and flavonol glycosides as active ingredients. This composition has been shown to effectively inhibit α-glucosidase activity and LDL oxidation, while also promoting insulin secretion and regulating gene expression. The extract has demonstrated an excellent ability to reduce waist/hip circumference ratios and improve various metabolic markers, highlighting its potential in combating metabolic syndrome.

Career Highlights

Choi has worked with esteemed institutions such as the Korea Institute of Science and Technology and the Korea Research Institute of Bioscience and Biotechnology. His research has focused on developing innovative solutions to pressing health issues, particularly those related to obesity and metabolic disorders.

Collaborations

Choi has collaborated with notable colleagues, including Tae-Sook Jeong and Song-Hae Bok, who have contributed to his research endeavors. Their combined expertise has further advanced the development of effective health solutions.

Conclusion

Myung-Sook Choi's innovative work in pharmaceutical compositions has the potential to significantly impact the fields of obesity and metabolic health. His patents reflect a commitment to improving health outcomes through scientific research and innovation.

Profile summary based on public USPTO records.